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Phospholipids are asymmetrically distributed at plasma membrane in normal cells, and 
scrambled in various biological situations such as blood clotting and apoptotic cell death. Recent 
studies revealed that phospholipid scrambling is mediated by at least two independent mechanisms. 
An eight transmembrane-containing protein TMEM16F Ca2+-dependently promotes the 
phospholipid scrambling, which is required for the PS exposure in activated platelets during blood 
clotting. On the other hand, a six transmembrane-containing protein Xk-related family protein 8 
(Xkr8) is activated by caspases during apoptosis, and promotes the phospholipid scrambling, thus 
exposing PS as an “eat-me-signal”. In this chapter, we describe the assay procedures for the 
phospholipid scrambling.  
 
1. Introduction 
Programmed cell death or apoptosis is characterized by DNA fragmentation, nuclear 
condensation, cell shrinkage, blebbing, and phosphatidylserine (PS) exposure (Vaux and Korsmeyer, 
1999; Nagata and Golstein, 1995). The anionic phospholipid PS is normally restricted to the inner 
side of the plasma membrane by an ATP-dependent flippase; P4-type ATPases are candidate 
flippases that have been demonstrated to have lipid transporting activities in cells (Balasubramanian 
and Schroit, 2003). During the process of apoptosis, flippase activity has been shown to be inhibited, 
although flippase inhibition alone is not sufficient for PS externalization (Bevers and Williamson, 
2010). A putative protein known as a calcium-dependent scramblase, which transports lipids 
bi-directionally and nonspecifically, must be activated (Bevers and Williamson, 2010). Following 
scramblase activation, PS and phosphatidylethanolamine (PE), which are initially located on the 
cytoplasmic side, are exposed to the cell surface, while phosphatidylcholine (PC) and sphingomyelin 
(SM), which are initially located on the extracellular side, are internalized. Once PS is exposed to the 
cell surface, it functions as an “eat-me-signal,” allowing apoptotic cells to be recognized and 
engulfed by phagocytes (Ravichandran and Lorenz, 2007; Nagata et al., 2010). The phospholipid 
scramblase also regulates PS exposure in activated platelets, to provide a scaffold for coagulation 
factors, whose activation is required to control bleeding (Zwaal et al., 1992). Although phospholipid 
scrambling resulting in PS exposure is important in many physiological situations, the molecular 
mechanism mediating this process was completely unknown until recently. Over the past few years, 
studies have begun to clarify the details involved in membrane lipid scrambling. In particular, we 
recently showed that whether apoptotic cells and activated platelets utilize the different protein(s) in 
promoting PS exposure. 
An eight transmembrane domain-containing protein, TMEM16F, was identified as an essential 
component involved in regulating calcium-dependent phospholipid scrambling (Suzuki et al., 2010). 
TMEM16F belongs to the 10-member TMEM 16 family. Mutations in TMEM16F have been 
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identified in patients with Scott syndrome and are associated with defective calcium 
activation-induced PS exposure, resulting in impaired thrombin generation and mild bleeding 
(Suzuki et al., 2010; Castoldi et al., 2011). Similarly, lymphocytes derived from TMEM16F 
knockout mice are defective in calcium-induced PS exposure (Yang et al., 2012; Suzuki et al., 
2013a); however, these cells exhibit normal PS exposure following apoptotic stimulation (Suzuki et 
al., 2013a), as also observed in lymphocytes derived from a Scott syndrome patient (Williamson et 
al., 2001). These results suggest that calcium- and apoptosis-induced phospholipid scrambling may 
be differentially regulated. Indeed, a six transmembrane domain-containing protein, Xk-related 
protein 8 (Xkr8) has been shown to regulate apoptosis-dependent phospholipid scrambling when it is 
cleaved by caspases (Suzuki et al., 2013b). The leukemia cell lines Raji and PLB985 are defective in 
apoptotic PS exposure (Fadeel et al., 1999; Fadok et al., 2001) due to a limited expression of Xkr8 
resulting from hypermethylation in the promoter region (Suzuki et al., 2013b). The exogenous 
expression of Xkr8 rescues phospholipid scrambling in these cells, confirming the importance of 
Xkr8 in this process. CED-8, the only Xkr8 homolog in C. elegans, also regulates PS exposure, 
promoting cell engulfment by phagocytes (Suzuki et al., 2013b), and indicating that the CED-8/Xkr8 
homologs share an evolutionarily conserved role in regulating phospholipid scrambling. In contrast, 
lymphocytes from Xkr8 knockout mice exhibit normal PS exposure upon calcium-ionophore 
stimulation, indicating that apoptotic- and calcium-induced PS exposure are differentially regulated 
by Xkr8 and TMEM16F, respectively. 
The following sections describe cell-based assays that we have developed for calcium- and 
apoptosis-induced phospholipid scrambling. 
 
2. Assays for calcium-induced phospholipid scrambling 
Early studies showed that the treatment of activated platelets with collagen plus thrombin 
facilitates PS exposure, leading to the enhanced conversion of prothrombin to thrombin by 
coagulation factors (Bevers et al., 1983). At the same time PS exposure is increased, cell surface 
sphingomyelin is decreased, suggesting that lipids are transported or scrambled from one side of the 
membrane to the other. This observation was confirmed by monitoring nitrobenzoxadiazole 
(NBD)-conjugated lipids in red blood cells and platelets stimulated with calcium (Smeets et al., 
1994; Williamson et al., 1995). Here, we describe PS and PE exposure assays, and NBD-PC and 
NBD-SM incorporation assays using activated lymphocytes.  
 
2.1. Cells, reagents and buffers 
2.1.1. Cells 
1. Ba/F3 cells (Palacios and Steinmetz, 1985) are maintained in RPMI1640 containing 10% fetal calf 
serum (FCS), 45 units/ml mouse IL-3, and 50 µM β-mercaptoethanol. 
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2. PLB985 cells (Tucker et al., 1987) are maintained in RPMI1640 containing 10% FCS and 50 µM 
β-mercaptoethanol. 
3. Immortalized fetal thymocytes (IFETs) (Imao and Nagata, 2013; Suzuki et al., 2013a) are cultured 
in DMEM containing10% FCS, 1 x non-essential amino acids (Gibco), 10 mM Hepes-NaOH 
buffer (pH 7.4), 50 µM β-mercaptoethanol, and GlutaMax (Gibco). 
 
2.1.2. Reagents 
1. PS exposure: AnnexinV-Cy5 (Biovision), Milk fat globule EGF factor 8 (MFG-E8)-FITC 
(Hematologic Technologies), Propidium Iodide (PI) (Sigma), Ca2+ ionophore A23187 (Sigma). 
2. PE exposure: Biotin-labeled Ro09-0198 (Dr. Umeda’s laboratory, Kyoto University), 
Streptavidin-APC (BD Biosciences). 
3. Lipid incorporation: 
1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholin
e (NBD-PC) (Avanti), 
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphingosine-1-phosphocholine 
(NBD-SM) (Avanti). NBD-lipids in chloroform were dried with nitrogen gas to avoid 
oxidization and resuspended in DMSO to a final concentration of 1 mM. NBD-lipids in DMSO 
can be stored at -20 oC for at least one month. 
 
2.1.3 Buffers 
1. Annexin buffer: 2.5 mM CaCl2, 140 mM NaCl, 10 mM Hepes-NaOH (pH 7.4). 
2. Lipid incorporation buffer: Hank's Balanced Salt Solution (HBSS) (Gibco), 1 mM CaCl2. 
3. Lipid extraction buffer: HBSS, 1 mM CaCl2, 5 mg/ml Fatty acid-free BSA (Sigma), 500 nM 
Sytox blue (Molecular Probes). 
 
2.2. Protocol for the phospholipid exposure assay 
PS exposure can be evaluated using the PS-binding proteins AnnexinV (Koopman et al., 1994) 
or MFG-E8 (Hanayama et al., 2002). PE exposure can be detected using the PE-binding peptide 
RO09-0198 (Emoto et al., 1997). In both cases, necrotic cells or membrane-broken cells can be 
identified by staining with PI or Sytox Blue. 
 
2.2.1. Phosphatidylserine exposure 
1. Transfer 2 ×106 cells to a 15-ml tube. 
2. Centrifuge (300 × g, 2 min, room temperature) and wash cells with 1 ml PBS. 
3. Centrifuge and wash cells with 1 ml Annexin buffer. 
4. Centrifuge and resuspend cells in 2 ml Annexin buffer. 
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5. Transfer 1 ml of the cell suspension to a 1.5-ml tube. 
6. Add 1 µl AnnexinV-Cy5 (1:1000) and 10 µl of 500 µg/ml PI (final concentration: 5 µg/ml). 
  *AnnexinV can be replaced with MFG-E8-FITC (final concentration: 83 ng/ml). 
7. Incubate in a heat block at 20 oC for 3 min. 
8. Transfer 500 µl of the stained cells to a FACS tube with a cap filter. 
9. Stimulate cells with 5 µl of 300 µM A23187 (final concentration: 3 µM). 
   *The A23187 concentration should be optimized for different cell types by titrating from 0.5 to 
10 µM. The optimal A23187 concentration was found to be 0.5 µM for Ba/F3 pro-B cells, 10 
µM for PLB985 myeloid progenitor cells, and 3 µM for IFETs. 
10. Analyze stained and activated cells by FACSAria at 20 oC. 
 
2.2.2. Phosphatidylethanolamine exposure 
At step 6 in the PS exposure assay, cells are resuspended in Annexin buffer with 
RO09-0198-biotin, Streptavidin-APC (1 µg/ml), and 5 µg/ml PI (the RO09-0198-biotin and 
Streptavidin-APC are mixed in Annexin buffer prior to use). The RO09-0198 concentration should 
be optimized. 
 
2.3. Protocol for the phospholipid incorporation assay 
Lipid incorporation can be observed using fluorescence-conjugated lipids (NBD-lipids) 
(Mclntyre and Sleight, 1991), and internalized lipids can be measured by the specific removal of 
outer layer lipids using fatty acid-free BSA (Haest et al., 1981). The ATP-dependent 
aminophospholipid translocases, or flippases, have the ability to incorporate PS and PE, but not PC 
(Colleau et al., 1991). While, scramblases non-specifically incorporate phospholipids (Williamson et 
al., 1992). Thus, NBD-PC is more suitable than NBD-PS to assay the scramblase. Necrotic cells or 
membrane-broken cells can be detected by staining with Sytox blue. It should be noted that A23187 
itself possesses a similar, but weak, fluorescence spectrum to Sytox blue. 
 
2.3.1. Nitrobenzoxadiazole-labeled phospholipid incorporation 
1. Transfer 4 ×106 cells to a 15-ml tube. 
2. Centrifuge (300 × g, 2 min, room temperature) and wash cells with 1 ml HBSS. 
3. Centrifuge and wash cells with 1 ml HBSS containing 1 mM CaCl2 (HBSS/CaCl2). 
4. Centrifuge and resuspend cells in 2 ml cold HBSS/CaCl2. 
5. Transfer 600 µl of the washed cells to two 1.5-ml tubes (one for DMSO and one for A23187). 
6. Incubate in an aluminum block on ice for 7 min. 
7. Add 600 µl of 200 nM NBD-PC dissolved in HBSS/ CaCl2 to the cell suspension (NBD-PC 
final concentration: 100 nM).  
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*The NBD-PC concentration should be optimized for different cell types by titrating from 0.1 
to 1 µM. 
8. Place the cell suspension on ice for 3 min. 
9. As a sample for time 0, mix 200 µl of the cell suspension with 200 µl of the chilled lipid 
extraction buffer, and keep on ice. 
10. To the remaining 1 ml cell suspension kept at step 8, add 5 µl DMSO or 5 µl 50 µM A23187 
(to a final concentration of 250 nM) to 1 ml cell suspension. *The A23187 concentration 
should be optimized for different cell types by titrating from 0.25 to 1 µM. 
11. Incubate in a heat block at 15 oC. 
*The incubation temperature can be increased up to 25 oC, but the cells may lyse at higher 
temperatures, depending on the cell type and the labeled lipid used. At lower temperature 
(15-25 oC), scramblase-independent incorporation (such as endocytosis) may be prevented. 
12. Collect 150-µl samples at 1, 2, 4, 6, and 8 min and add to 150 µl of the chilled lipid extraction 
buffer or the same buffer without BSA, and keep on ice. 
13. Analyze the Sytox blue-negative population of the applied cells for the incorporated NBD-PC 
by flow cytometry. The BSA-non-extractable NBD-PC signal represents incorporated lipids 
that have been internalized. The BSA-non-treated NBD-PC signal represents total lipids, 
including those attached to the cell surface and those that have been internalized.  
 
3. Assays for apoptosis-induced phospholipid scrambling 
PS exposed on the cell surface was first suggested to be an “eat-me-signal” by studies in which 
red blood cells were labeled with the fluorescence-conjugated PS (NBD-PS); unincorporated 
NBD-PS remaining on the surface of the red blood cells was found to facilitate their uptake by 
macrophages (Tanaka and Shroit, 1983). Approximately 10 years later, apoptotic lymphocytes 
exposing PS were shown to be engulfed by phagocytes in a PS-dependent manner (Fadok et al., 
1992). When PS is exposed to the cell surface, PC or SM, located on the outer surface of the 
membrane become internalized, suggesting the existence of proteins that transport lipids 
bi-directionally and nonspecifically (Williamson et al., 2001). Here, we describe PS and PE 
exposure assays and NBD-PC and NBD-SM incorporation assays using apoptotic leukocytes. 
 
3.1. Cells, reagents, and buffer  
3.1.1. Cells 
1. WR19L cells (ATCC, #TIB-52) expressing mouse Fas (Ogasawara et al., 1993) are maintained in 
RPMI1640 containing 10% FCS and 50 µM β-mercaptoethanol. 




3. Culture condition of PLB985 cells is described in 2.1.1. 
 
3.1.2. Reagents 
   Most of the reagents and buffers used here were described in section 2.1.2. The reagents used 
specifically in this section include: Fas ligand and staurosporine (Kyowa Hakko) to induce 
apoptosis.  
Fas Ligand 
The leucine-zipper tagged human Fas ligand (Shiraishi et al., 2004) was prepared by introducing 
its expression vector into COS-7 cells. In brief, one hundred fifty µg of the expression vector was 
mixed with 3x107 COS-7 cells in 3 ml of kPBS (30.8 mM NaCl, 121 mM KCl, 8.1 mM Na2HPO4, 
1.46 mM KH2PO4) and subjected to electroporation using a Gene-pulser (960 µF, 0.23 kV) 
(Bio-Rad). After electroporation, the cells in ten 10-cm plates were cultured for 3 days in DMEM 
containing 1% FCS, and the culture supernatant was collected. The cells were further cultured for 
two days with fresh medium, and the conditioned medium was combined with the medium collected 
at day 3 (a total of 150 ml). A 225 ml of saturated ammonium sulfate was added to the conditioned 
medium at 4 oC to obtain 60% saturation of ammonium sulfate, and the proteins were precipitated by 
centrifugation at 15,000 g for 30 min. The precipitated proteins were dissolved in 4 ml of PBS, 
dialyzed against PBS, filtered through a 0.22 µm filter, and stored at -80 oC until use. The biological 
activity of Fas ligand was determined with WR19L cells expressing mouse Fas as described (Tanaka 
et al., 1997), and one unit is defined as the dilution that gives a half-maximum response. 
 
3.2. Protocol for the phospholipid exposure assay 
Like the Ca2+-induced PS exposure, PS exposed during apoptosis can be detected using the 
PS-binding proteins Annexin V (Koopman et al., 1994) or MFG-E8 (Hanayama et al., 2002), while 
PE exposure is detected with RO09-0198 (Emoto et al., 1997). Apoptotic cells later undergo 
secondary necrosis, and these cells are stained by AnnexinV and PI (or Sytox blue). 
 
3.2.1. Phosphatidylserine exposure 
1. Transfer 5 ×105 cells in 500 µl medium to a 24-well plate. 
2. Stimulate cells with adequate apoptotic stimuli. 
  WR19L cells expressing mouse Fas are stimulated with 10 units/ml Fas ligand for 60 min. 
  Raji cells are stimulated with 400 units/ml Fas ligand for 2 h. 
   PLB985 cells suspended in PBS are exposed to 2000 J/m2 UV irradiation and cultured in 
medium for 2 to 3 h, or treated with 10 µM staurosporine for 2 to 4 h. 
3. Transfer 230 µl of the cell suspension to a 96-well round-bottom plate. 
4. Centrifuge (300 g, 2 min, 4 oC) and wash cells with 200 µl PBS. 
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5. Centrifuge and wash cells with 200 µl Annexin buffer. 
6. Centrifuge and resuspend cells in 100 µl Annexin buffer containing AnnexinV-Cy5 (1:1000). 
7. Incubate cells on ice for 15 min. 
8. Add 100 µl Annexin buffer containing 10 µg/ml PI. 
9. Incubate cells on ice for 2 min. 
10. Analyze stained cells with flow cytometry. 
 
3.2.2. Phosphatidylethanolamine exposure 
The cells are treated with apoptotic stimuli as described above (steps 1 to 5).  
 6. Centrifuge and resuspend cells in 100 µl Annexin buffer with biotin-RO09-0198. 
 7. Incubate cells on ice for 15 min. 
 8. Add 100 µl Annexin buffer, centrifuge, and wash cells with 200 µl Annexin buffer. 
9. Centrifuge and resuspend cells in 100 µl Annexin buffer with Streptavidin-APC (1 µg/ml). 
10. Incubate cells on ice for 15 min. 
11. Add 100 µl Annexin buffer, centrifuge, and wash cells with 200 µl Annexin buffer. 
12. Centrifuge and resuspend cells in 200 µl Annexin buffer containing 5 µg/ml PI. 
13. Analyze stained cells with flow cytometry. 
 
3.3. Protocol for the phospholipid incorporation assay 
Like the Ca2+-induced scrambling of phospholipids, the scrambling of phospholipids during 
apoptosis can be monitored using NBD-PC, and internalized lipids can be distinguished from those 
bound to the cells by the specific removal of outer layer lipids using fatty acid-free BSA (Haest et al., 
1981). The apoptotic PS exposure is caspase-dependent (Martin et al., 1996), and when the cells 
undergo the secondary necrosis, phospholipid scrambling may occur at the membrane-broken sites 
in a scramblase-independent fashion. Thus, timing to assay the scramblase activity in apoptotic cells 
is critical. 
 
3.3.1. Nitrobenzoxadiazole-labeled phospholipid incorporation 
Cells were stimulated with apoptotic stimuli as described above (3.2.1).  
1. Transfer 2 ×106 cells to a 15-ml tube. 
2. Centrifuge (300 × g, 2 min, room temperature) and wash cells with 1 ml HBSS. 
3. Centrifuge and wash cells with 1 ml HBSS/CaCl2. 
4. Centrifuge and resuspend cells in 1 ml cold HBSS/CaCl2. 
5. Transfer 600 µl of the cell suspension to a 1.5-ml tube. 
6. Incubate in an aluminum block on ice for 7 min. 
7. Add 600 µl of 200 nM NBD-lipids in HBSS/ CaCl2 to the cell suspension (NBD-lipids final 
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concentration: 100 nM). *NBD-lipid concentration should be optimized for different cell types 
by titrating from 0.1 to 1 µM. 
8. Place the cell suspension on ice for 3 min. 
9. As a sample for time 0, mix 200 µl of the cell suspension with 200 µl of the chilled lipid 
extraction buffer, and keep on ice. 
10. Place the remaining 1 ml cell suspension at step 8 onto a heat block, and incubate at 20 oC. 
11. Take 150-µl aliquots at 1, 2, 4, 6, and 8 min and mix with 150 µl of lipid extraction buffer or 
the same buffer without BSA, and keep on ice. 




Figure 1. Ca2+-induced scrambling of phospholipids promoted by TMEM16F. 
(A) Ca2+ ionophore-induced PS exposure. The wild-type and TMEM16F-/- IFETs were treated at 
20°C with 3.0 µM A23187, and Annexin V-binding to the cells was monitored by flow cytometry 
for 10 min. (B) Ca2+ ionophore-induced lipid internalization. The wild-type and TMEM16F-/- IFETs 
were treated at 15°C with 250 nM A23187 in the presence of NBD-PC. Using aliquots of the 
reaction mixture, the BSA-non extractable level of NBD-PC in the Sytox Blue-negative population 
was determined at the indicated time by flow cytometry and shown in mean fluorescence intensity. 
 
Figure 2 Apoptosis-induced scrambling of phospholipids promoted by Xkr8. 
(A and B) Apoptotic exposure of PS and PE. PLB-985 and PLB-985 transformants expressing Xkr8 
were treated with staurosporine (STS), stained with AnnexinV-Cy5 (A) or biotin-RO 
peptide/APC-streptavidin (B), and PI, and analyzed by flow cytometry. (C and D) Scrambling of PC 
and SM in apoptotic cells. PLB-985 and PLB-985-transformants expressingXkr8 were treated with 
STS and incubated with NBD-PC (C) or NBD-SM (D), and the incorporated lipids were analyzed by 
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